Effect of Smoking on Saliva Composition and the Development of Dental Erosion
Launched by UNIVERSITY OF GÖTTINGEN · Dec 19, 2019
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteers aged between 20 and 50 years who are able to give written consent
- Exclusion Criteria:
- • Non-fulfillment of the inclusion criteria
- • Intake of medications or diseases altering salivary secretion
- • Refusal to use fluoridated toothpastes
- • Known allergies to substances used in the study
- • Orthodontic treatment or malfunction which does not allow wearing an intraoral device
About University Of Göttingen
The University of Göttingen, a prestigious research institution located in Germany, is committed to advancing medical science through innovative clinical trials. Renowned for its interdisciplinary approach, the university leverages expertise across various fields to conduct rigorous studies aimed at improving patient outcomes. With a focus on ethical research practices and robust scientific methodologies, the University of Göttingen collaborates with leading healthcare professionals and institutions to explore novel therapeutic strategies and contribute to the global understanding of health and disease. Its dedication to fostering academic excellence and translating research findings into clinical applications positions it as a key player in the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Göttingen, Lower Saxony, Germany
Patients applied
Trial Officials
Annette Wiegand, Prof. Dr. med. dent.
Principal Investigator
Dept. of Prev. Dentistry, Periodontology and Cariology, University Medical Center Göttingen, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials